SCHEMBL6131692

SCHEMBL6131692

CCOC(=O)C(Cc1ccc(Nc2nccc3ccncc23)cc1)NC1=CC(=O)C12CCOCC2

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGA4 P13612 4/20 0.39
ITGB1 P05556 3/20 0.39
ELANE P08246 1/20 0.35
PTGS2 P35354 1/20 0.33
CDK2 P24941 1/20 0.33
FLT3 P36888 1/20 0.33
CCNA1 P78396 1/20 0.33
HDAC3 O15379 2/20 0.32
HDAC1 Q13547 2/20 0.32
HDAC6 Q9UBN7 2/20 0.32
MAPT P10636 7/20 0.32
NPSR1 Q6W5P4 2/20 0.32
KDM4E B2RXH2 1/20 0.32
CYP1A2 P05177 1/20 0.32
CYP3A4 P08684 1/20 0.32
CYP2D6 P10635 1/20 0.32
CYP2C9 P11712 1/20 0.32
CYP2C19 P33261 1/20 0.32
GAA P10253 6/20 0.31
ITGB7 P26010 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6131694 1.00 ITGA4 (0.39) ITGA4ITGB1ELANEPTGS2CDK2
SCHEMBL3832796 0.92 ITGB1 (0.47) ITGA4ITGB1ELANEHDAC3HDAC1
SCHEMBL3836794 0.86 ITGA4 (0.43) ITGA4ITGB1ELANEPTGS2HDAC3
SCHEMBL6131688 0.85 ITGB1 (0.44) ITGA4ITGB1ELANEPTGS2HDAC3
SCHEMBL3836314 0.85 ITGB1 (0.44) ITGA4ITGB1ELANEPTGS2HDAC3
SCHEMBL3835880 0.83 ITGB1 (0.46) ITGA4ITGB1ELANEMAPTNPSR1
SCHEMBL2978998 0.82 ITGB1 (0.55) ITGA4ITGB1CYP3A4CYP2C9
SCHEMBL5575175 0.82 ITGB1 (0.55) ITGA4ITGB1CYP3A4CYP2C9
SCHEMBL5149363 0.81 ITGB1 (0.43) ITGA4ITGB1ELANEHDAC3HDAC1
Ucb-1184197 SCHEMBL6131680 0.79 ITGB1 (0.47) ITGA4ITGB1CYP3A4CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6951943-B2 Process for the preparation of phenylalanine enamide derivatives CELLTECH R & D LIMITED (GB) 2005-10-04 US disclosed
US-20040073033-A1 Process for the preparation of phenylalanine enamide derivatives UCB PHARMA S.A. (BE) 2004-04-15 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040073033-A1 Process for the preparation of phenylalanine enamide derivatives NPY2R, NPY1R, NPR1 ITGA4 3960/4885ITGB1 4148/4885ELANE 855/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.